Skip to main content
. Author manuscript; available in PMC: 2018 Jan 1.
Published in final edited form as: J Pediatr Hematol Oncol. 2017 Jan;39(1):20–25. doi: 10.1097/MPH.0000000000000707

Table 1.

Demographic and clinical characteristics of survivors.

DS & AML n=26 AML, No DS**: (n=21) P value*:
Age at diagnosis
 median in years (range) 1.8 (0.77-10.9) 1.5 (0.06-4.8) 0.27
Age at interview
 median in years (range) 15.0 (8.3-27.6) 10.6 (8.1-18.3) 0.003
Time since diagnosis
 median in years (range) 12.8 (6.8-19.6) 8.7 (6.7-18.1) 0.003
QOL physical summary score median (range) 45.8 (10.0-58.7) 54.0 (6.4-57.4) 0.16
QOL physical summary score mean (SD) 41.2 (15.0) 47.7 (12.2) 0.11ˆ
QOL psychosocial summary score median (range) 45.6 (28.0-59.1) 50.3 (15.5-62.1) 0.28
QOL psychosocial summary score mean (SD) 45.3 (8.4) 46.3 (13.6) 0.75ˆ
Gender 0.63
 Male 13 (50%) 9 (42.9%)
 Female 13 (50%) 12 (57.1%)
Race 0.55
 White (including Hispanic) 22 (84.6%) 19 (90.5%)
 Nonwhite 4 (15.4%) 2 (9.5%)
Treatment study 0.003
 CCG213/213P 8 (30.8%) 0
 CCG 251 5 (19.2%) 1 (4.8%)
 CCG2891 13 (50.0%) 20 (95.2%)
Chronic health conditions 0.07
 Yes 20 (76.9%) 8 (50.0%)
 No 6 (23.1%) 8 (50.0%)
Any severe chronic health condition (grade III or IV) 0.40
 Yes 6 (23.1%) 2 (12.5%)
 No 20 (76.9%) 14 (87.5%)
Two or more chronic health conditions 0.23
 Yes 13 (50.0%) 5 (31.3%)
 No 13 (50.0%) 11 (68.7%)
Three or more chronic health conditions 0.39
 Yes 8 (30.8%) 3 (18.8%)
 No 18 (69.2%) 13 (81.2%)
Reports general health 0.57
 Excellent, very good or good 23 (88.5%) 15 (93.7%)
 Fair or poor 3 (11.5%) 1 (6.3%)
Has pain as a result of cancer n/a
 Yes 0 0
 No 26 (100.0%) 16 (100%)
Has anxiety as a result of cancer 0.95
 Yes 5 (19.2%) 3 (20.0%)
 No 21 (80.8%) 12 (80.0%)
Functional impairment 0.002
 Yes 18 (69.2%) 3 (18.8%)
 No 8 (30.8%) 13 (81.2%)
Activity limitation 0.27
 Yes 5 (19.2%) 1 (6.7%)
 No 21 (80.8%) 14 (93.3%)
Need help in personal cares 0.06
 Yes 8 (30.8) 1 (6.3%)
 No 18 (69.2%) 15 (93.7%)
*

2-sided P value based on Wilcoxon rank sum test for continuous measures (ˆ for P values from two-sample t-test) and Chi-square test for categorical measures.

**

Survivors without Down syndrome whose proxy caregiver completed the CHQ PF50. Of these 16 also completed the CCSS baseline questionnaire.